Loading clinical trials...
Loading clinical trials...
Venous thromboembolism (VTE) has considerably harmful effects on morbidity and mortality of cancer patients. Several guidelines recommendations have been made about the use of anticoagulation for the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seoul National University Bundang Hospital
NCT07350499 · Arterial Thromboembolism, Venous Thromboembolism, and more
NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT07213778 · Symptomatic Venous Thromboembolism (VTE)
NCT06764875 · HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions